@article{MAKHILLTC2014918455,
    title = {Introduction to New Oral Anticoagulants (NOAC’s)},
    journal = {The Cardiology},
    volume = {9},
    number = {1},
    pages = {7-10},
    year = {2014},
    issn = {1811-8194},
    doi = {tcard.2014.7.10},
    url = {https://makhillpublications.co/view-article.php?issn=1811-8194&doi=tcard.2014.7.10},
    author = {Rohan,Ryan,Kais and},
    keywords = {PubMed databases,rivaroxaban,NOAC’s,physicians,potential},
    abstract = {To produce a high quality article for physicians that reviews 
  the current literature pertaining to NOAC’s, 
  in particular, their use in clinical practice, known drug interactions and side 
  effect profile. Medline, Cochrane and PubMed databases were searched for the 
  most recent and clinically sound articles pertaining apixaban, rivaroxaban and 
  dabigatran. Researchers found the trials for each of these NOAC’s 
  to be sound and have results that can be translated into clinical practice.}
    }